WO2006111776A3 - Pharmaceutical composition comprising serum obtained from a naive mammal - Google Patents

Pharmaceutical composition comprising serum obtained from a naive mammal Download PDF

Info

Publication number
WO2006111776A3
WO2006111776A3 PCT/GB2006/050085 GB2006050085W WO2006111776A3 WO 2006111776 A3 WO2006111776 A3 WO 2006111776A3 GB 2006050085 W GB2006050085 W GB 2006050085W WO 2006111776 A3 WO2006111776 A3 WO 2006111776A3
Authority
WO
WIPO (PCT)
Prior art keywords
serum obtained
pharmaceutical composition
naive mammal
naive
mammal
Prior art date
Application number
PCT/GB2006/050085
Other languages
French (fr)
Other versions
WO2006111776A2 (en
Inventor
Deirdre Mcintosh
Original Assignee
Aimsco Ltd
Deirdre Mcintosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimsco Ltd, Deirdre Mcintosh filed Critical Aimsco Ltd
Publication of WO2006111776A2 publication Critical patent/WO2006111776A2/en
Publication of WO2006111776A3 publication Critical patent/WO2006111776A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Pharmaceutical compositions comprising serum obtained from non-immunised mammals, particularly ungulates, and more particularly goats, are described, together with methods for their preparation. The compositions are particularly useful for the treatment of multiple sclerosis, optic neuritis, rheumatoid arthritis, and HIV, but have applicability to a wide range of conditions.
PCT/GB2006/050085 2005-04-22 2006-04-24 Pharmaceutical composition comprising serum obtained from a naive mammal WO2006111776A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0508153.4 2005-04-22
GBGB0508153.4A GB0508153D0 (en) 2005-04-22 2005-04-22 Therapeutic agent

Publications (2)

Publication Number Publication Date
WO2006111776A2 WO2006111776A2 (en) 2006-10-26
WO2006111776A3 true WO2006111776A3 (en) 2006-12-14

Family

ID=34639951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/050085 WO2006111776A2 (en) 2005-04-22 2006-04-24 Pharmaceutical composition comprising serum obtained from a naive mammal

Country Status (2)

Country Link
GB (1) GB0508153D0 (en)
WO (1) WO2006111776A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170274013A1 (en) * 2013-09-16 2017-09-28 Patrick T. Prendergast Wound fluid elevated protease enzyme inhibition through camelid blood products
ES2690178A1 (en) * 2017-05-18 2018-11-19 Apc Europe Slu PLASMA OF ANIMAL OR FRACTIONS OF THE SAME FOR ITS USE IN THE TREATMENT OF DISORDERS OF COGNITIVE DETERIORATION IN HUMAN BEINGS AND ANIMALS OF COMPANY (Machine-translation by Google Translate, not legally binding)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033136A1 (en) * 1998-06-25 2000-09-06 Chengdu Shuyang Pharmaceutical Factory The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant
WO2003004049A2 (en) * 2001-07-02 2003-01-16 Aimsco Limited Use of polyclonal anti-hiv goat serum as a therapeutic agent
WO2003064472A2 (en) * 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033136A1 (en) * 1998-06-25 2000-09-06 Chengdu Shuyang Pharmaceutical Factory The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant
WO2003004049A2 (en) * 2001-07-02 2003-01-16 Aimsco Limited Use of polyclonal anti-hiv goat serum as a therapeutic agent
WO2003064472A2 (en) * 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. SISTI ET AL.: "Preparation of lyophilized and liquid intravenous immunoglobulin G: development and scale-up.", VOX SANGUINIS, vol. 80, no. 4, May 2001 (2001-05-01), Basel, Switzerland, pages 216 - 224, XP002230242 *
B. VAN ENGELEN ET AL.: "Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis.", ANNALS OF NEUROLOGY, vol. 32, no. 6, December 1992 (1992-12-01), Boston, MA, USA, pages 834 - 835, XP000995657 *

Also Published As

Publication number Publication date
WO2006111776A2 (en) 2006-10-26
GB0508153D0 (en) 2005-06-01

Similar Documents

Publication Publication Date Title
WO2007076032A3 (en) Compositions and methods for producing a composition
WO2008076348A8 (en) Crystalline solid rasagiline base
WO2007079139A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2006012492A3 (en) Compositions and methods for viscosupplementation
WO2007127841A3 (en) Compositions and methods of preparation thereof
WO2006028936A3 (en) Heteromultimeric molecules
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2006096489A3 (en) Anti-m-csf antibody compositions having reduced levels of endotoxin
WO2005112938A3 (en) Disalt inhibitors of il-12 production
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2007134279A3 (en) Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
WO2007136841A3 (en) Digital alloys and methods for forming the same
WO2009038683A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2005110428A3 (en) Resistance-repellent retroviral protease inhibitors
WO2006074202A3 (en) Synthesis of hybrid block copolymers and uses thereof
WO2009015383A3 (en) Crystallizable polyetherimides, method of manufacture, and articles derived therefrom
WO2008112192A3 (en) Epha3 antibodies for the treatment of solid tumors
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2007127506A8 (en) Anti-ephrinb2 antibodies and methods using same
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
WO2005105079A3 (en) Novel imidazoles
WO2006060542A3 (en) Formulations of substituted benzoxazoles
WO2021222746A3 (en) THERAPEUTIC SIRPα ANTIBODIES
WO2005094364A3 (en) Iga antibody protein as a cytotoxic drug

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06727181

Country of ref document: EP

Kind code of ref document: A2